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ABSTRACT 
Experimental studies show that detrimental effects of ischemia-reperfusion (I/R) injury can be 
attenuated by hyperoxic preconditioning in normal hearts, however, there are few studies 
about hyperoxia effects in diseased myocardium. The present study was designed to assess the 
cardioprotective effects of hyperoxia pretreatment (≥ 95 % O2) in acute diabetic rat hearts. 
Normal and one week acute diabetic rats were either exposed to 60 (H60) and 180 (H180) 
min of hyperoxia or exposed to normal atmospheric air (21 % O2). Then hearts were isolated 
immediately and subjected to 30 min of regional ischemia followed by 120 min of reperfu-
sion. Infarct size, cardiomyocyte apoptosis, enzymes release and ischemia induced arrhythmi-
as were determined. Heart of diabetic control rats had less infarct size and decreased LDH and 
CK-MB release compared to normal hearts. 60 and 180 min of hyperoxia reduced myocardial 
infarct size and enzymes release in normal hearts. 180 min of hyperoxia also decreased car-
diomyocytes apoptosis in normal state. On the other hand, protective values of hyperoxia 
were not significantly different in diabetic hearts. Moreover, hyperoxia reduced severity of 
ventricular arrhythmias in normal rat hearts whereas; it did not confer any additional anti-
arrhythmic protection in diabetic hearts. These findings suggest that diabetic hearts are less 
susceptible to ischemia-induced arrhythmias and infarction. Hyperoxia greatly protects rat 
hearts against I/R injury in normal hearts, however, it could not provide added cardioprotec-
tive effects in acute phase of diabetes.  
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INTRODUCTION 
Ischemic preconditioning (IPC) is an 
endogenous phenomenon in which brief 
periods of ischemia and reperfusion (I/R) 
render a tissue more resistant to subsequent 
severe ischemic injury (Murry et al., 1986). 
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Beneficial effects of IPC have been demon-
strated in a variety of organs including the 
heart (Rajesh et al., 2004). Preconditioning 
(PC) can also be induced by several other 
stimuli, such as hypoxia (Cohen et al., 
1995; Neckar et al., 2002), oxidative stress 
(Baines et al., 1997), heat stress (Yamashita 
et al., 1997) and lipopolysaccharides 
(Rowland et al., 1997). Most of these 
stimuli, however, lack potential for clinical 
application due to associated complication.  
Pre-exposure to hyperoxia was shown 
to induce protective effects against ische-
mia-reperfusion (I/R) injury in different tis-
sues, including the heart (Bigdeli et al., 
2007; Esmaili Dehaj et al., 2009; Rasoulian 
et al., 2008), perhaps through the generation 
of oxygen free radicals and induction of 
low graded oxidative stress (Tiravanti et al., 
2007; Zhang et al., 2004). These beneficial 
effects of hyperoxia have been proved 
clearly in normal myocardium (Tahepold et 
al., 2003; Tiravanti et al., 2007), however 
little is known whether mechanisms of hy-
peroxic preconditioning are operating in 
pathologically altered myocardium. The 
easy clinical application of hyperoxia draws 
the attention with the development of its 
basic research especially in pathologic sta-
tus of complicating disease such as diabe-
tes.  
Diabetes mellitus is a major risk factor 
for myocardial infarction and death and 
leads to an increased incidence of myocar-
dial ischemia as well as mortality following 
ischemia (Wang and Chatham, 2004). Ac-
cordingly, reducing the consequences of 
coronary artery disease using strategies that 
target I/R injury would be particularly valu-
able in diabetic population. Therefore, the 
current study was designed to examine the 
beneficial effects of in vivo hyperoxia pre-
exposure against I/R injuries in streptozoto-
cin-induced acute diabetic rat heart. 
 
MATERIALS AND METHODS 
Animals and study design 
Male Wistar rats (250–350 g) fed a 
standard diet and tap water ad libitum and 
housed at 12:12-h light-dark cycle in a 
stress-free environment. The experimental 
protocols were approved by Tarbiat Mo-
dares University Ethics Committee for ani-
mal research. 
The present study was performed in two 
experiments, normal (N) and diabetic (D) 
condition. Three groups of animals (7-11 
rats in every group) were assessed in each 
experiment including control group (C), 
60 min hyperoxia pretreatment group (H60) 
and 180 min hyperoxia pretreatment group 
(H180). Animals in hyperoxia groups were 
kept in a hyperoxic chamber (≥ 95 % O2), 
while non-diabetic and diabetic control an-
imals were kept in the same chamber 
breathing normal atmospheric air (21 % 
O2). Oxygen was continuously delivered at 
a rate of 0.5-1 l/min into the chamber. The 
percentage of oxygen was continuously 
monitored with an oxygen meter (Lutron–
DO 5510, Taiwan). Immediately after pre-
treatment with normoxia or hyperoxia, the 
hearts were excised for Langendorff perfu-
sion. After a stabilization time of 20 min, 
the hearts were exposed to 30 min of re-
gional ischemia, followed by 120 min of 
reperfusion in all experiments.  
 
Induction of diabetes 
Diabetes was induced by a single injec-
tion of streptozotocin (50 mg/kg, i.v.) dilut-
ed in buffer solution (0.1 M citrate buffer, 
pH 4.5). Development of the diabetes was 
confirmed by enhanced blood glucose lev-
els (400-600 mg/dl). One week following 
induction of the diabetes, the animals were 
subjected to the experimental protocol. 
 
Perfusion technique 
Rats were anaesthetized (pentobarbital 
sodium 60 mg/kg, i.p.) and heparinized 
(300-400 IU, i.p.). Hearts were rapidly ex-
cised, placed in ice-cold Krebs–Henseleit 
buffer, cannulated via the aorta and per-
fused by the Langendorff method. Epical 
electrocardiogram (ECG) and left ventricu-
lar pressure were continuously recorded 
during the ischemia and reperfusion using a 
PowerLab analog to digital converter (AD 
Instruments, Australia). Coronary flow 
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(CF) was measured by timed collections of 
the coronary effluent. Left ventricular sys-
tolic (LVSP) and end-diastolic (LVEDP) 
pressures were obtained by a latex water-
filled balloon inserted into the left ventricle 
via the left atrium and connected to a pres-
sure transducer (MLT 844). At the end of 
stabilization period, the volume of the bal-
loon was adjusted to obtain end-diastolic 
pressure of 5–7 mm Hg and was unchanged 
for the remainder of the experiment. Left 
ventricular developed pressure (LVDP) was 
calculated as "LVSP–LVEDP". Rate pres-
sure product (RPP) as an index of cardiac 
function was calculated by multiplying 
LVDP with heart rate (HR). 
 
Induction of ischemia and reperfusion 
A 5-0 silk suture was loosely placed 
under the left anterior descending coronary 
artery (LAD) 2 to 3 mm from its origin by 
inserting the needle into the left ventricular 
wall. Two ends of the suture were threaded 
through a 10 mm segment of sampler tip. 
Tightening and loosening this snare allowed 
the coronary artery occlusion and reperfu-
sion, respectively (Curtis, 1998). 
 
Determination of infarct size 
At the end of 120 min reperfusion, the 
coronary artery was re-occluded, and the 
area at risk (AAR) was delineated by per-
fusing 1 ml of 2 % Evans blue solution into 
the aortic cannula. After freezing at -20 °C, 
hearts were cut into transverse slices of 
2 mm thickness from apex to base and slic-
es were stained in 1 % triphenyl tetrazolium 
chloride (TTC, Sigma) at 37 °C for 20 min. 
The slices were then photographed by a 
digital camera (Olympus, FE–160). AAR 
and infarct size were determined by com-
puterized planimetry using image analysis 
software (Image Tool). Infarct size was cal-
culated as percentage of AAR. 
 
In situ nick end labeling 
To determine myocardial apoptosis in a 
quantitative manner, five rats in each group 
were studied in an additional experiment. 
At the end of reperfusion, the hearts were 
washed with 0.9 % saline for 5 min , fol-
lowed by 4 % paraformaldehyde in 0.1 M 
phosphate buffer saline (PBS, pH 7.4) for 
10 min. AAR was cut and further fixed in 
4 % paraformaldehyde in PBS for 48 h at 
room temperature. Fixed tissues were then 
embedded in a paraffin block. TUNEL 
staining was performed according to the 
manufacturer’s protocol (Roche, Germany). 
In brief, 4-μm thick sections of the heart 
blocks were deparaffinized by two xylene 
wash and rehydrated by a descending etha-
nol series and then washed with phosphate-
buffered saline. The sections were subse-
quently incubated with 20 μg/ml proteinase 
K for 15 min at room temperature, and en-
dogenous peroxidase was inactivated by the 
treatment with 3 % hydrogen peroxide in 
methanol for 10 min. After 3 times wash 
with PBS and drying, sections were incu-
bated with 50 μl of TUNEL reaction mix-
ture, containing terminal deoxynucleotidyl 
transferase (TdT) and fluorescein-dUTP for 
1 h at 37 °C. After end labeling was com-
pleted, the sections were washed with PBS 
and incubated with anti-fluorescein anti-
body conjugated with POD for 30 min at 
37 °C. For the color development, 100 μl 
DAB was applied to the sections for 15 min 
at room temperature. Finally, the sections 
were counterstained with hematoxylin. Af-
ter the procedures, 1000 nuclei in different 
regions in the area at risk were examined by 
light microscopy at a magnification of 400, 
and the number of TUNEL-positive myo-
cyte nuclei (dark brown color) were count-
ed and expressed as a percentage of the to-
tal number of myocyte nuclei in the AAR 
(% Apoptosis). 
 
Estimation of lactate dehydrogenase 
(LDH) and creatine kinase (CK-MB)  
release 
LDH and CK-MB activities were de-
termined spectrophotometrically (TECH-
NICON RA–1000) using standard kits (Pars 
Azmun, Iran) for assessment of myocardial 
damage. The enzyme activities were ex-
pressed as units per liter. 
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Quantification of arrhythmias  
Arrhythmias were defined according to 
the Lambeth Conventions (Walker et al., 
1988). Accordingly, arrhythmias were cate-
gorized as premature ventricular beats 
(PVBs, defined as discrete premature ven-
tricular depolarization), ventricular tachy-
cardia (VT, a run of four or more consecu-
tive ventricular premature beats) and ven-
tricular fibrillation (VF, a signal where in-
dividual QRS deflections could not easily 
be distinguished from each other). More 
complex forms of premature ventricular 
beats (bigeminy and salvos) were included 
in the count of ventricular premature beats 
and were not analyzed separately. 
Electrograms were analyzed for (1) the 
total number of premature ventricular beats 
(TPVBs) and (2) the incidence and duration 
of ventricular tachycardia and ventricular 
fibrillation during 30 min of ischemia. In 
addition, severity of arrhythmias was quan-
tified by a scoring system. Each individual 
heart was evaluated by means of a 5-point 
arrhythmia score, where single PVBs were 
given a score of 1, bigeminy/salvos a score 
of 2, VT a score of 3, VF a score of 4, sus-
tained VF (VF lasting more than two 
minutes) a score of 5 and an assigned num-
ber corresponded to the most severe type of 
arrhythmia observed in that heart. Scores 
were used for group analysis of severity of 
arrhythmias. 
 
Statistics 
Data were expressed as means ± SEM. 
The incidence of arrhythmias was presented 
as percentage of occurrence. Differences in 
the recovery of postischemic functional pa-
rameters, CK-MB and LDH were tested by 
two-way analysis of variance (ANOVA) 
with repeated measures on one factor, tak-
ing treatment as an independent factor and 
time as a dependent factor. Comparisons of 
infarct size, myocyte apoptosis and ar-
rhythmias number were performed by one-
way ANOVA with Duncan posthoc analy-
sis. Differences in the arrhythmias score, 
VT and VF episodes number and duration 
between the groups were compared by the 
Mann–Whitney U test. P<0.05 was consid-
ered statistically significant.  
 
RESULTS 
Cardiac function parameters 
As shown in Table 1, the baseline func-
tional parameters including HR, LVDP, 
RPP and CF were not significantly different 
between the control and hyperoxia pre-
treatment groups both in normal and diabet-
ic conditions. During reperfusion, 60 and 
180 min of hyperoxia significantly im-
proved coronary flow in normal hearts 
compared to respective control group 
(p<0.05 and p<0.001 respectively) whereas, 
there was no difference in values of diabetic 
hearts pretreated with hyperoxia versus dia-
betic control group. No important differ-
ences were found between normal and dia-
betic controls with respective hyperoxia 
treated groups regarding the values of HR, 
LVDP and RPP during reperfusion. The 
heart functional parameters were not 
changed in control diabetic hearts compared 
to control normal ones. 
 
Myocardial infarct size  
In the control normal group 39.5 ± 
3.6 % of AAR was necrotic at the end of 
2 h reperfusion. Pretreatment with 60 and 
180 min hyperoxia reduced infarct size to 
26.3 ± 2.3 (p<0.05) and 20.4 ± 2.6 % 
(p<0.01) respectively. There was no differ-
ence between two normal hyperoxia treated 
groups. Infarct size was also decreased in 
diabetic control hearts compared to normal 
control ones (14.5 ± 2.8 vs. 39.5 ± 3.6 %, 
p<0.001). Hyperoxia for 60 and 180 min 
did not cause further reduction in infarct 
size in the diabetic animals (Figure 1a).  
 
 
 
 
 
 
EXCLI Journal 2012;11:263-273 – ISSN 1611-2156 
Received: April 10, 2012, accepted: May 29, 2012, published: June 11, 2012 
 
267 
Table 1: Haemodynamic measurements in Langendorff-perfused rat hearts subjected to 30 min of 
regional ischemia and 120 min of reperfusion 
Parameters/groups Stabilization Reperfusion20 min 30 min 60 min 90 min 120 min
Non-diabetic hearts
HR (beats/min)  
C 301±8 263±15 262±17 263±22 241±19
H60 299±11 322±15* 310±15* 288±14 274±14
H180 333±18 299±16 300±16 288±17 278±18
LVDP (mmHg)  
C 76.9±3.3 74.0±2.8 70.4±2.0 65.9±1.8 61.4±1.4
H60 80.7±3.9 72.7±1.0 69.5±1.2 67.1±1.3 66.6±0.8
H180 75.8±3.4 77.8±1.2 72.5±1.7 71.0±1.7 68.1±1.0*
RPP(mmHg.beats/min)  
C 23126±988 19149±1283 18383±1527 17132±1289 14752±1134
H60 24032±1259 23382±1051* 21518±979 19350±962 18270±918*
H180 25101±1422 23267±1470* 21864±1463* 20653±619 19000±1314*
CF (ml/min)  
C 10.4±0.9 7.8±1.2 6.6±0.8 5.1±0.5 4.6±0.5
H60 10.1±0.5 9.4±0.9* 7.6±0.4 6.3±0.8* 5.5±0.8*
H180 10.3±1.1 10.9±0.6* 8.9±0.5* 7.7±0.4* 6.6±0.7*
Diabetic hearts
HR (beats/min)  
C 300±14 273±7.0 260±10 250±9.0 242±10
H60 270±10 283±16 261±16 256±19 240±16
H180 296±18 293±11 282±12 263±14 243±13
LVDP (mmHg)  
C 73.0±3.4 76.1±4.0 69.7±3.6 62.5±3.0 60.4±2.4
H60 81.8±3.5 84.1±4.9 73.7±4.8 66.8±3.8 63.5±3.6
H180 80.2±3.6 80.9±4.6 76.0±3.7 72.0±4.9 69.5±2.3
RPP(mmHg.beats/min)  
C 21966±1715 20684±1121 17977±902.0 15506±573.0 14493±560.0
H60 21953±887.0 23604±1577 18900±1123 16894±1173 15150±1071
H180 23335±1169 23695±1655 21572±1576 19093±1429 16921±1191
CF (ml/min)  
C 10.2±0.8 8.5±0.6 6.8±0.5 5.5±0.4 4.3±0.4
H60 9.9±0.6 8.9±0.5 7.4±0.5 6.3±0.5 5.4±0.7
H180 10.3±0.5 8.9±0.5 7.0±0.6 5.7±0.4 4.8±0.4
 
* Groups are as follows: (1) Non-diabetic groups: C, control; H60, 60 min hyperoxia immediately before 
heart isolation; H180, 180 min hyperoxia immediately before heart isolation. (2) Diabetic groups: C, con-
trol; H60, 60 min hyperoxia immediately before heart isolation; H180, 180 min hyperoxia immediately be-
fore heart isolation. HR, heart rate; LVDP, left ventricular developed pressure; RPP, rate pressure prod-
uct; CF, coronary flow. Data presented as means ± SEM. One-way ANOVA was used for comparison of 
functional parameters at each time point. *p<0.05 compared to respective control group at each time point 
 
 
Myocytes apoptosis 
Total numbers of myocyte nuclei were 
counted in the AAR of histological sections 
obtained from each heart. The TUNEL pos-
itive nuclei were observed only in the AAR 
and the number of TUNEL positive nuclei 
in nonrisk region of the heart was sparse. 
The percentage of TUNEL positive nuclei 
was significantly reduced by 180 min of 
hyperoxia pretreatment in normal hearts 
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(17.5 ± 3.5 % in H180 vs. 31 ± 2.3 % of 
control group, p<0.05), showing an attenu-
ating effect of normobaric hyperoxia pre-
exposure against I/R induced apoptosis. In 
contrast, number of TUNEL positive nuclei 
in the area at risk region of diabetic hearts 
was not significantly changed by hyperoxia 
pretreatment (Figure 1b).  
 
 
Figure 1: (a) Infarct size expressed as percent-
age of area at risk (AAR) in normal and diabetic 
rat hearts after 30 min ischemia and 120 min of 
reperfusion. (b) Percentage of TUNEL positive 
nuclei in AAR of left ventricle in non-diabetic 
and diabetic rat hearts. Data presented as 
mean ± SEM. * p<0.05, ** p<0.01 and *** 
p<0.001 compared to respective control group. 
$$$ p<0.001, diabetic control vs. normal control 
group 
 
Lactate dehydrogenase (LDH) and crea-
tine kinase (CK-MB) leakage 
The extent of reperfusion induced injury 
was determined by measuring the extent of 
CK and LDH enzymes release into the cor-
onary effluent (Figure 2a, b). In normal 
control group the values of LDH and CK 
release into the effluent at reperfusion were 
148 ± 7 and 66 ± 5 U/L respectively. Pre-
treatment with hyperoxia, remarkably de-
creased the amount of LDH and CK release 
to 97 ± 8 and 37 ± 4 U/L in H60 and to 86 ± 
6 and 31 ± 4 U/L in H180 groups respec-
tively (p<0.001). Induction of diabetes, de-
creased the amount of LDH and CK release 
to 73.91 ± 6.71 and 16.96 ± 2.13 vs. 148 ± 
7 and 66 ± 5 U/L in normal control group, 
p<0.001). In the diabetic hearts, 180 min 
hyperoxia reduced the extent of LDH re-
lease in the coronary effluent (41.62 ± 4.95 
vs. 73.91 ± 6.71 U/L, p<0.01) whereas, hy-
peroxia could not significantly change the 
extent of CK-MB release in diabetic hearts. 
 
 
 
 
Figure 2: LDH (a) and CK (b) release in coro-
nary effluent of control and hyperoxia pretreat-
ment groups in normal and diabetic hearts. Da-
ta presented as mean ± SEM. ** p<0.01 and 
*** p<0.001 compared to respective control 
group. $$$ p<0.001, diabetic control vs. normal 
control group 
 
 
Ischemia-induced arrhythmias 
Occlusion of LAD coronary artery 
caused severe ventricular arrhythmias. The 
duration of arrhythmias was affected by 
hyperoxia. In normal hearts, the total dura-
tion of VT and VF was significantly re-
duced by 60 and 180 min of hyperoxia pre-
treatment (22.39 ± 5.96 and 24.65 ± 19.28 s 
respectively vs. 63.36 ± 7.56 s in control, 
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p<0.05). Diabetic hearts showed an en-
hanced resistance to ischemia induced ar-
rhythmias and the total duration of VT and 
VF was markedly suppressed (7.56 ± 3.78 
vs. 63.36 ± 16.24 in normal group, 
p<0.001). The effect of hyperoxia was not 
evident in diabetic hearts (Figure 3). Num-
ber of VT and VF episodes was decreased 
by both 60 and 180 min of hyperoxia pre-
treatment in normal hearts (Figure 4a, b). 
Induction of diabetes was accompanied by 
a decrease in number of VT episodes (Fig-
ure 4a) and completely abolished VF inci-
dence and episodes number (Figure 4b). 
Number of VT episodes did not significant-
ly change by hyperoxia in diabetic hearts 
(Figure 4a) and VF episodes in diabetic hy-
peroxia groups remained zero (Figure 4b). 
Severity of ischemia induced arrhyth-
mias (evaluated by means of arrhythmia 
score) was also assessed. 60 and 180 min of 
hyperoxia pretreatment reduced arrhythmia 
score compared to normal group (2.9 ± 0.18 
and 2.87 ± 0.22 vs. 3.54 ± 0.20 respective-
ly, p<0.05). In diabetic control group sever-
ity was significantly lower compared to 
normal (2.87 ± 0.12 vs. 3.54 ± 0.20, 
p<0.05). Hyperoxia, however, failed to re-
duce the severity of arrhythmias in diabetic 
hearts (Figure 5). 
 
Figure 3: Total sum of VT and VF duration dur-
ing 30 min ischemia. Data presented as mean ± 
SEM. * p<0.05 compared to normal control 
group. $$$ p<0.001, diabetic control vs. normal 
control group 
 
 
 
Figure 4: Number of VT (a) and VF (b) epi-
sodes during 30 min ischemia. Data presented 
as mean ± SEM. * p<0.05 compared to normal 
control group. $ p<0.05, diabetic control vs. 
normal control group 
 
 
Figure 5: Arrhythmias severity evaluated by 
means of arrhythmia score. Data presented as 
mean ± SEM. * p<0.05 compared to normal 
control group. $ p<0.05, diabetic control vs. 
normal control group 
 
 
DISCUSSION 
The first finding of the present study is 
that one week acute diabetes led to a great 
cardioprotection by reducing infarct size 
and severity of ischemic arrhythmias. How-
ever, hyperoxia pretreatment fails to confer 
additional protection in diabetic hearts. In 
addition hyperoxia induced significant pro-
tective effect in normal rats, in accordance 
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with previous studies (Choi et al., 2006; 
Esmaili Dehaj et al., 2009).  
Hyperoxic preconditioning is thought to 
have useful cardioprotective effects against 
I/R injury. Simplicity and easy clinical ap-
plicability of O2 pretreatment cause it to 
become a potential clinical preconditioning 
tool in the near future (Tahepold et al., 
2002). However, it remains unknown 
whether hyperoxic preconditioning is still 
effective when certain co-morbidities ac-
company the ischemic heart disease. Thus, 
our study has investigated whether the ben-
eficial effects of hyperoxic preconditioning 
can be preserved in diabetes which is a 
common clinical condition and predisposes 
to coronary artery disease (Monteiro et al., 
2005).  
Although results obtained from clinical 
studies of diabetic cardiomyopathy suggests 
an increased risk of myocardial infarction 
and a rate of mortality, experimental results 
are not consistent to each other and point 
out to increased, unchanged or decreased 
susceptibility to ischemia-reperfusion injury 
in different experimental conditions 
(Ravingerova et al., 2000a).  
The results of the present study show 
that one week of diabetes could not signifi-
cantly alter the cardiac function parameters 
compared to non-diabetic control group, 
whereas infarct size and severity of ischem-
ic arrhythmias were markedly reduced by 
diabetes. These results are consistent with 
the results obtained by other researchers. 
Ravingerova et al. (2003, 2000b) have 
shown that acute diabetes markedly sup-
presses ischemic arrhythmias and infarct 
size in rat heart models. In accord, Tosaki 
et al. (1996) have demonstrated a reduction 
in the incidence of reperfusion-induced ar-
rhythmias in the rat heart in the early phase 
of diabetes. Other studies of short term 
STZ-induced diabetes in rats have reported 
decreased apoptotic index as indicated by 
reduced cleaved caspase-3 as a marker of 
apoptosis (Ma et al., 2006). Our data also 
showed that percent of apoptotic myocytes 
tends to decrease (non-significant) in area 
at risk of diabetic hearts compared normal 
ones. This result is consistent with the re-
duction in infarct size in the diabetic rats. 
Taken together, these findings indicate that 
acute diabetes activates some of cardiopro-
tective mechanisms, which in turn reduce 
ischemia-reperfusion injuries.  
One of the proposed mechanisms of in-
creased heart tolerance to injury in diabetic 
condition is the concept of metabolic pre-
conditioning. According to this, the meta-
bolic and secondary molecular and cellular 
changes which occur in cardiomyocytes 
after diabetes might be responsible for en-
hanced myocardial resistance to ischemia 
(Hadour et al., 1998). Diabetes decreases 
rate of glycolysis, and alleviates degree of 
intracellular acidosis in ischemia (Feuvray 
and Lopaschuk, 1997). Moreover it has 
been shown that type 1 diabetes decreases 
activity of sarcolemmal Na+/Н+ exchanger 
which in turn, may lead to limitation of 
Ca2+ inward current through Na+/Ca2+ ex-
changer in cardiomyocytes, and therefore 
may retard the irreversible I/R injury 
(Feuvray and Lopaschuk, 1997). 
On the other hand, increased myocardial 
tolerance to I/R injury in diabetes may be 
due to difference in hemodynamic parame-
ters between control and diabetic animals. It 
is known that lower values of blood pres-
sure and heart rate are associated with 
smaller cardiac performance and, hence, 
smaller myocardial oxygen demand (Ma et 
al., 2006) however, this factor was disre-
garded in present study, since there were no 
differences between non-diabetic control 
and diabetic animals in hemodynamic pa-
rameters.  
The most important finding of the pre-
sent study was the different response of 
normal and diabetic hearts to hyperoxic 
preconditioning. Until now studies related 
to the role of hyperoxia in heart precondi-
tioning have only been performed in normal 
condition. In this study, 60 and 180 min of 
hyperoxia significantly reduced infarct size 
and ischemia-induced arrhythmias in the 
non-diabetic hearts, while it did not confer 
any additional protection in one-week dia-
betic rat hearts. Decreased protective value 
of hyperoxic preconditioning seen in dia-
betic hearts may be due to the great protec-
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tive effect induced by diabetes itself and 
this cardioprotective effect which is already 
induced by diabetes, could potentially mask 
the additional protective value of hyperoxic 
preconditioning seen in normal hearts. 
 Studies demonstrate that in both condi-
tions common protective mechanisms, such 
as activation of protein kinase C (Choi et 
al., 2006), as well as opening of KATP chan-
nels (Tiravanti et al., 2007) have been im-
plicated. PKC activation and KATP channels 
opening play major roles in ischemic pre-
conditioning. It has been suggested that al-
teration in the activity of these protective 
mediators in acute phase of diabetes induce 
heart protection (Malhotra et al., 1997; 
Moon et al., 1999; Smith and Wahler, 
1996). Thus the protective effects, which 
were seen in the hyperoxia pretreated dia-
betic hearts, may be due to the effects of 
diabetes, hyperoxia or combination of both. 
Although possible beneficial effects of hy-
peroxia against I/R injury in diabetic hearts 
were not clear in the present study, we 
could not conclude that hyperoxic exposure 
had not any effects in diabetic rat hearts. It 
may be due to limitation of the current 
study including, the protocol or duration of 
hyperoxic gas exposure and/or duration of 
diabetes. 
In conclusion, the results of the present 
study show that normobaric hyperoxia pre-
treatment reduces infarct size, myocytes 
apoptosis and protects the heart against is-
chemic arrhythmias. Early period of diabe-
tes is associated with an increased myocar-
dial resistance to cell damage and decreased 
severity of ischemic arrhythmias. Hyperox-
ia does not exert obvious additional cardio-
protective effect in acute diabetic hearts.  
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